Simvastatin can inhibit the HIF-1α/PPAR-γ/PKM2 axis and suppress PKM2-mediated glycolysis, resulting in decreased tumor cell proliferation and increased apoptosis in a xenograft hepatocellular carcinoma (HCC) mouse model [30]. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.